Protection of Women and Girls in Sports Act of 2025
Sponsor

- Conservative Groups$1,774k
Full profile: /officials/T000278
Source: Congress.gov · FEC
Cosponsors (44)
Members who have signed on to support this bill since introduction. Source: Congress.gov.
44 cosponsors on record at Congress.gov. The named list is syncing into Govwatch and will appear here shortly — view on Congress.gov in the meantime.
Latest Action
The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →
Cloture on the motion to proceed to the measure not invoked in Senate by Yea-Nay Vote. 51 - 45. Record Vote Number: 100. (CR S1455-1456)
2025-03-03
Source: Congress.gov
Plain-English Summary
Protection of Women and Girls in Sports Act of 2025 This bill generally prohibits school athletic programs from allowing individuals whose biological sex at birth was male to participate in programs that are for women or girls. Specifically, the bill provides that it is a violation of Title IX of the Education Amendments of 1972 for federally funded education programs or activities to operate, sponsor, or facilitate athletic programs or activities that allow individuals of the male sex to participate in programs or activities that are designated for women or girls. (Title IX prohibits discrimination on the basis of sex in federally funded education programs or activities, including in public elementary and secondary schools and in colleges and universities.) Under the bill, sex is based on an individual's reproductive biology and genetics at birth.
Plain-English rewrite of the Congressional Research Service summary published on Congress.gov. Cached and reviewed.
Subjects
Related legislation
Bills by the same sponsor or covering overlapping subjects.
- S4974Making America's Food Safer ActPassed Senate · 2026-10-05
- S5485Americans First Immigration ActReferred to Committee · 2026-09-23
- S4978Stop Settlement Slush Funds Act of 2026Referred to Committee · 2026-07-14
- S4692Homeopathic Drug Product Safety, Quality, and Transparency ActReferred to Committee · 2026-06-04